These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19054590)

  • 21. Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey.
    Suemitsu R; Yamaguchi M; Takeo S; Ondo K; Ueda H; Yoshino I; Maehara Y
    Ann Thorac Cardiovasc Surg; 2008 Jun; 14(3):154-60. PubMed ID: 18577893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of PTEN expression is not uncommon, but lacks prognostic value in stage I NSCLC.
    Olaussen KA; Soria JC; Morat L; Martin A; Sabatier L; Morere JF; Khayat D; Spano JP
    Anticancer Res; 2003; 23(6C):4885-90. PubMed ID: 14981940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers.
    Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S
    Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.
    Horio Y; Takahashi T; Kuroishi T; Hibi K; Suyama M; Niimi T; Shimokata K; Yamakawa K; Nakamura Y; Ueda R
    Cancer Res; 1993 Jan; 53(1):1-4. PubMed ID: 8380124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
    Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
    Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
    Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
    Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of aminopeptidase N in non-small cell lung cancer.
    Tokuhara T; Hattori N; Ishida H; Hirai T; Higashiyama M; Kodama K; Miyake M
    Clin Cancer Res; 2006 Jul; 12(13):3971-8. PubMed ID: 16818694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma.
    Luboldt HJ; Kubens BS; Rübben H; Grosse-Wilde H
    Cancer Res; 1996 Feb; 56(4):826-30. PubMed ID: 8631020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
    Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
    Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer.
    Nakamura T; Suzuki K; Mochizuki T; Ohde Y; Kobayashi H; Nakamura H; Toyoda F
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):321-4. PubMed ID: 19059950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
    Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
    Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.
    Pennathur A; Lindeman B; Ferson P; Ninan M; Quershi I; Gooding WE; Schuchert M; Christie NA; Landreneau RJ; Luketich JD
    Ann Thorac Surg; 2009 Mar; 87(3):893-9. PubMed ID: 19231415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
    Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.